Literature DB >> 26709879

Temporal lobe volume predicts Wada memory test performance in patients with mesial temporal sclerosis.

Kan Ding1, Yunhua Gong2, Pradeep N Modur3, Ramon Diaz-Arrastia4, Mark Agostini5, Puneet Gupta6, Roderick McColl7, Ryan Hays8, Paul Van Ness9.   

Abstract

The Wada test is widely used in the presurgical evaluation of potential temporal lobectomy patients to predict postoperative memory function. Expected asymmetry (EA), defined as Wada memory lateralized to the nonsurgical hemisphere, or a higher score after injection of the surgical hemisphere would be considered favorable in terms of postoperative memory outcome. However, in some cases, nonlateralized memory (NM) results, with no appreciable asymmetry, may occur because of impaired scores after both injections, often leading to denial of surgery. The reason for such nonlateralized Wada memory in patients with intractable temporal lobe epilepsy (TLE) remains unclear. Given that quantitative morphometric magnetic resonance imaging studies in TLE patients have shown bilateral regional atrophy in temporal and extratemporal structures, we hypothesized that the volume loss in contralateral temporal structures could contribute to nonlateralized Wada memory performance. To investigate this, we examined the relationship between the volume changes of temporal structures and Wada memory scores in patients with intractable TLE with mesial temporal sclerosis (MTS) using an age- and gender-matched control group. Memory was considered nonlateralized if the absolute difference in the total correct recall scores between ipsilateral and contralateral injections was <11%. Among 21 patients, Wada memory was lateralized in 15 and nonlateralized in 6 patients, with all the nonlateralized scores being observed in left TLE. The recall scores after ipsilateral injection were significantly lower in patients with an NM profile than an EA profile (23 ± 14% vs. 59 ± 18% correct recall, p ≤ 0.001). However, the recall scores after contralateral injection were low but similar between the two groups (25 ± 17% vs. 25 ± 15% correct recall, p=0.97). Compared to controls, all the patients showed greater volume loss in the temporal regions. However, patients with a NM profile showed significantly more volume loss than those with a lateralized memory profile in both contralateral and ipsilateral temporal regions (p<0.05). Left hemispheric Wada memory performance correlated positively with the size of the left mesial and neocortical temporal structures (r=0.49-0.63, p=0.005-0.04). Our study suggests that volume loss in the nonsurgical temporal structures is associated with nonlateralized Wada memory results in patients with intractable TLE.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mesial temporal sclerosis; Regional atrophy; Temporal lobe epilepsy; Wada test

Mesh:

Year:  2015        PMID: 26709879      PMCID: PMC4740193          DOI: 10.1016/j.eplepsyres.2015.11.018

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  19 in total

1.  Memory outcome after left anterior temporal lobectomy in patients with expected and reversed Wada memory asymmetry scores.

Authors:  D S Sabsevitz; S J Swanson; G L Morris; W M Mueller; M Seidenberg
Journal:  Epilepsia       Date:  2001-11       Impact factor: 5.864

2.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

3.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

4.  Left hippocampal pathology is associated with atypical language lateralization in patients with focal epilepsy.

Authors:  Bernd Weber; Jörg Wellmer; Markus Reuber; Florian Mormann; Susanne Weis; Horst Urbach; Jürgen Ruhlmann; Christian E Elger; Guillén Fernández
Journal:  Brain       Date:  2005-12-05       Impact factor: 13.501

5.  Neocortical thinning in "benign" mesial temporal lobe epilepsy.

Authors:  Angelo Labate; Antonio Cerasa; Umberto Aguglia; Laura Mumoli; Aldo Quattrone; Antonio Gambardella
Journal:  Epilepsia       Date:  2011-03-31       Impact factor: 5.864

6.  Cortical thickness analysis in temporal lobe epilepsy: reproducibility and relation to outcome.

Authors:  Boris C Bernhardt; Neda Bernasconi; Luis Concha; Andrea Bernasconi
Journal:  Neurology       Date:  2010-06-01       Impact factor: 9.910

7.  Bilateral Memory Dysfunction in Epilepsy Surgery Candidates Detected by the Intracarotid Amobarbital Procedure (Wada Memory Test).

Authors:  Ramon Diaz-Arrastia; Alan B. Frol; Maria C. Garcia; Mark A. Agostini; David P. Chason; Laura H. Lacritz; C Munro Cullum; Paul C. Van Ness
Journal:  Epilepsy Behav       Date:  2002-02       Impact factor: 2.937

8.  Diffusion tensor tractography of traumatic diffuse axonal injury.

Authors:  Jun Yi Wang; Khamid Bakhadirov; Michael D Devous; Hervé Abdi; Roddy McColl; Carol Moore; Carlos D Marquez de la Plata; Kan Ding; Anthony Whittemore; Evelyn Babcock; Tiffany Rickbeil; Julia Dobervich; David Kroll; Bao Dao; Nisha Mohindra; Christopher J Madden; Ramon Diaz-Arrastia
Journal:  Arch Neurol       Date:  2008-05

9.  Widespread neocortical abnormalities in temporal lobe epilepsy with and without mesial sclerosis.

Authors:  S G Mueller; K D Laxer; J Barakos; I Cheong; P Garcia; M W Weiner
Journal:  Neuroimage       Date:  2009-02-26       Impact factor: 6.556

10.  Regional neocortical thinning in mesial temporal lobe epilepsy.

Authors:  Carrie R McDonald; Donald J Hagler; Mazyar E Ahmadi; Evelyn Tecoma; Vicente Iragui; Lusineh Gharapetian; Anders M Dale; Eric Halgren
Journal:  Epilepsia       Date:  2008-02-07       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.